Thanks, Rajiv. While recent market and booking activity is encouraging and growth since the 2020 second quarter shutdowns has been better than expected, the level of our future bookings is still uncertain. The trend line for bookings is improving, but improvements are occurring at a decreasing rate, and the COVID-19 cases are increasing. Overall, we continue to operate on the assumption that the economic and market environment will remain difficult throughout the remainder of 2020, with COVID-19 cases expected to increase in areas entering the winter season. And in 2021 as well, until an effective COVID-19 vaccination or alternative therapy is widely available.
While we may not be able to control the macroeconomic factors that drive the demand for our product, we are aggressively executing on actions that are within our control to keep our employees healthy as COVID-19 cases once again spike in many of the countries around the globe and on moderating any resulting additional near-term financial impact from the continuing COVID-19 pandemic.
Beginning late in the first quarter, we put in plans -- we put in place plans to mitigate the impact of declining markets and bookings and the consequential impact of reduced manufacturing activity from pandemic related shutdowns by initiating cost reduction measures, which were designed to lower cost and enhance liquidity. Despite currently improving markets, we expect these measures to remain in place until the market and economic uncertainty dissipates and results improve, which we anticipate will occur over the course of 2021.
We expect these cost reduction actions to achieve $60 million to $75 million in operating expense savings in 2020 compared to 2019, of which approximately $47 million have been realized through the end of the third quarter.
As Rajiv has mentioned, we also adjusted production levels at our manufacturing plants during the 2020 second quarter to align them more closely with the anticipated reduced demand in targeted booking levels. Throughout the third quarter, we increased production moderately to adjust for improved market levels, and we anticipate increasing production further in the fourth quarter given the expected bookings and backlog, barring, of course, any new government shutdown.
Based on our current backlog levels and plant production levels, we expect to have adequate components supply and minimal open production slots over the remainder of the year. This is expected to position us with both competitive lead times and acceptable ongoing backlog. We will continue to focus on adjusting production levels quickly to match the market and booking changes and work -- and working closely with our suppliers to ensure appropriate component supply as our production levels change. Given these factors, we expect our fourth quarter 2020 operating profit and net income to be significantly higher than both 2020 third quarter and the prior year fourth quarter.
Let me take a step back and explain that our expectations for the 2020 fourth quarter were established prior to the most recent spikes of COVID-19 cases as seen in a number of countries, including our largest markets. This environment could develop into a headwind for our current fourth quarter booking expectations. Further, we, or some of our suppliers, may need to shut down.
Renewed measures have already been taken in a number of European countries that mitigate the spread of virus and similar actions are likely to be taken by other countries. At this time, the new measures put in place have not had a significant impact on our plants or suppliers. However, we are monitoring the evolving situation, including monitoring closely a number of suppliers based in areas where cases are spiking. We are prepared to take further actions, if necessary, to maintain the health and safety of our global employees and to address any production of supply chain issues, which may develop. More broadly, as a result, the pandemic related uncertainties continue to limit our ability to forecast booking levels for 2021.
In addition to our focus on cost containment actions, we have also focused on actions to enhance our cash flow before financing, including reducing our working capital and reducing or deferring capital expenditures, which we now expect capital expenditures to be approximately $61 million for the full year 2020. Our 2020 third quarter cash flow before financing improved significantly over the second quarter and over the prior year third quarter, helping to generate $46.3 million of cash flow before financing for the 9 months ended September 30, 2020.
Enhancing our liquidity potential also continues to be a priority. At September 30, 2020, our cash on hand was $89.9 million, and debt was at $297.7 million compared to cash on hand of $60.5 million and debt of $337.7 million at the end of the second quarter. Encouragingly, our net debt improved $69.4 to $207.8 million from $277.2 million at the end of the second quarter. In addition, as of September 30, we have unused borrowing capacity of approximately $260 million under our existing revolving credit facilities compared with $218 million at the end of the second quarter.
Looking to the future, in the context of an improving booking trends, we plan to increase our investment in working capital to support the forecasted growth in our business. Al, if your line is now secure, can you -- I'll return the call back to you.